Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells. Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers ...

Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells in the body. They differ based on which type of blood cell is ...

Myeloproliferative neoplasms (MPNs) are a group of blood cancers that occur when your bone marrow makes too many red blood cells, white blood cells, or platelets. If you have one of these cancers ...

Polycythemia vera and essential thrombocythemia are the most common chronic myeloproliferative neoplasms; their molecular basis has been appreciated only recently and is briefly discussed in this ...

Myeloproliferative diseases are a heterogeneous group of conditions characterized by excessive cellular proliferation of one or more types of peripheral blood cells. Allogenic haematopoietic stem ...

In this regard, a large, randomized, multicenter trial (Myeloproliferative Disorders Research Consortium Clinical Trial-112), comparing treatment with Peg-IFN-α2a to HU in high-risk patients with ...